Medications

Use of certain prescription meds linked to COVID-19 mortality

(HealthDay)—A potential COVID-19 survival benefit is suggested in association with initiation or continuation of an angiotensin-converting enzyme inhibitor (ACE-I), an angiotensin receptor blocker (ARB), or metformin for ...

Diabetes

USPSTF: Evidence lacking for T2DM screening in children

(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient for assessing the benefits and harms of type 2 diabetes screening in children and adolescents (I statement). ...

Medications

New study reveals metformin-dependent antitumor immunity

Modern medicine has made slow progress in combating the menace of cancer. With all the permutations and combinations of cancer affecting millions of people worldwide, a blanket, yet targeted therapy would be ideal. Recently, ...

Medications

Study shows low adherence to diabetes medication

Groups who suffer the highest burden of type 2 diabetes have the lowest level of adherence to effective medication to control it, a University of Otago study has found.

page 5 from 31